From Rettland Foundation Facebook page:
We are thrilled to share some very exciting news! Neuren Pharmaceuticals has partnered with Rettland Foundation to provide travel reimbursement for the upcoming trofinetide study in Rett Syndrome. Please visit http://www.rettstudy.com/resources/ to learn more.
Twelve study sites have been selected and are at various stages of IRB approval. We look forward to sharing enrollment information once each site becomes active to recruitment.
Comment: So far only 11 sites are listed on the rettstudy web page.
From the RettStudy web site:
Travel Reimbursement
All families are eligible to receive travel reimbursement while participating in the Rett-002 study. The Rettland Foundation will administer funds to reimburse families for reasonable costs incurred.*
Rett Study
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.070(0.35%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $20.22 | $20.44 | $19.85 | $4.194M | 209.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2772 | $19.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 3310 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |